Carroll Financial Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $264K | Buy |
3,153
+524
| +20% | +$40.9K | 0.01% | 339 |
|
|
2021
Q3 | $198K | Buy |
2,629
+235
| +10% | +$18.7K | 0.01% | 394 |
|
|
2021
Q2 | $194K | Buy |
2,394
+26
| +1% | +$2.13K | 0.01% | 419 |
|
|
2021
Q1 | $186K | Sell |
2,368
-280
| -11% | -$21.9K | 0.01% | 408 |
|
|
2020
Q4 | $226K | Sell |
2,648
-102
| -4% | -$8.43K | 0.02% | 341 |
|
|
2020
Q3 | $212K | Hold |
2,750
| – | – | 0.02% | 335 |
|
|
2020
Q2 | $201K | Hold |
2,750
| – | – | 0.02% | 332 |
|
|
2020
Q1 | $182K | Sell |
2,750
-75
| -3% | -$5.29K | 0.02% | 312 |
|
|
2019
Q4 | $194K | Sell |
2,825
-54
| -2% | -$3.68K | 0.02% | 367 |
|
|
2019
Q3 | $211K | Sell |
2,879
-1,775
| -38% | -$129K | 0.02% | 350 |
|
|
2019
Q2 | $333K | Sell |
4,654
-26
| -0.6% | -$1.85K | 0.03% | 268 |
|
|
2019
Q1 | $320K | Buy |
4,680
+216
| +5% | +$14K | 0.03% | 247 |
|
|
2018
Q4 | $267K | Buy |
4,464
+472
| +12% | +$29.5K | 0.03% | 229 |
|
|
2018
Q3 | $267K | Sell |
3,992
-1,188
| -23% | -$79.1K | 0.03% | 244 |
|
|
2018
Q2 | $335K | Buy |
5,180
+241
| +5% | +$15.8K | 0.04% | 217 |
|
|
2018
Q1 | $354K | Sell |
4,939
-245
| -5% | -$17.6K | 0.04% | 208 |
|
|
2017
Q4 | $391K | Sell |
5,184
-262
| -5% | -$19.1K | 0.04% | 194 |
|
|
2017
Q3 | $398K | Sell |
5,446
-192
| -3% | -$13.8K | 0.05% | 182 |
|
|
2017
Q2 | $417K | Hold |
5,638
| – | – | 0.05% | 181 |
|
|
2017
Q1 | $412K | Sell |
5,638
-33
| -0.6% | -$2.31K | 0.05% | 167 |
|
|
2016
Q4 | $371K | Buy |
5,671
+202
| +4% | +$13.8K | 0.05% | 170 |
|
|
2016
Q3 | $405K | Buy |
5,469
+178
| +3% | +$13.2K | 0.06% | 162 |
|
|
2016
Q2 | $387K | Buy |
5,291
+60
| +1% | +$4.27K | 0.06% | 160 |
|
|
2016
Q1 | $369K | Buy |
5,231
+362
| +7% | +$24.1K | 0.07% | 159 |
|
|
2015
Q4 | $324K | Buy |
4,869
+245
| +5% | +$16.3K | 0.07% | 159 |
|
|
2015
Q3 | $309K | Buy |
4,624
+334
| +8% | +$21.8K | 0.07% | 158 |
|
|
2015
Q2 | $281K | Buy |
4,290
+890
| +26% | +$60.4K | 0.06% | 157 |
|
|
2015
Q1 | $236K | Buy |
3,400
+3,200
| +1,600% | +$221K | 0.1% | 121 |
|
|
2014
Q4 | $14K | Hold |
200
| – | – | 0.01% | 436 |
|
|
2014
Q3 | $13K | Sell |
200
-311
| -61% | -$20.5K | ﹤0.01% | 523 |
|
|
2014
Q2 | $35K | Buy |
511
+45
| +10% | +$3.02K | 0.01% | 375 |
|
|
2014
Q1 | $30K | Buy |
466
+66
| +17% | +$4.16K | 0.01% | 357 |
|
|
2013
Q4 | $26K | Sell |
400
-266
| -40% | -$17K | 0.01% | 377 |
|
|
2013
Q3 | $39K | Buy |
666
+266
| +67% | +$15.8K | 0.01% | 322 |
|
|
2013
Q2 | $22K | Buy |
+400
| New | +$23.7K | 0.01% | 318 |
|
Other funds holding CL
Carroll Financial Associates's CL Position: Q4 2021 in Review
Carroll Financial Associates increased its Colgate-Palmolive (CL) stake by 20% in Q4 2021, buying an estimated $40.9K and bringing the position to 3,153 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #339.
Carroll Financial Associates first reported a position in CL in Q2 2013 and has held it in 35 quarters since. The position peaked at $417K in Q2 2017. 1,704 funds tracked by Wall St. Rank hold CL as of Q4 2021.
- Carroll Financial Associates held 3,153 shares of Colgate-Palmolive worth $264K as of Q4 2021.
- Carroll Financial Associates bought 524 Colgate-Palmolive shares in Q4 2021, an estimated $40.9K.
- Colgate-Palmolive made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #339 holding.
- Carroll Financial Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Colgate-Palmolive position peaked at $417K in Q2 2017.
- 1,704 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.